Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis

Published:2023-06-27 Issue:6 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Virgili Gianni¹,Curran Katie²,Lucenteforte Ersilia³,Peto Tunde⁴,Parravano Mariacristina⁵

Affiliation:

1. Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA); University of Florence; Florence Italy

2. Belfast UK

3. Department of Clinical and Experimental Medicine; University of Pisa; Pisa Italy

4. Centre for Public Health; Queen's University Belfast; Belfast UK

5. Ophthalmology; Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS; Rome Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Reference188 articles.

1. Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial;Baker;JAMA,2019

2. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2;Michaelides;Ophthalmology,2010

3. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3;Rajendram;Archives of Ophthalmology,2012

4. Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT Study (Report 4);Sivaprasad;PloS ONE,2013

5. Ranibizumab versus aflibercept for diabetic macular edema: 18-month results of a comparative, prospective, randomized study and multivariate analysis of visual outcome predictors;Chatzirallis;Cutaneous and Ocular Toxicology,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-07-12

2. How do anti-vascular endothelial growth factors (anti-VEGFs) compare with one another for people with diabetic macular edema?;Cochrane Clinical Answers;2023-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3